federal_register: 2013-27770

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2013-27770 Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling." When finalized, the draft guidance will replace the guidance of the same title issued January 25, 2012. The draft guidance clarifies the requirements for product name placement, size, prominence, and frequency in promotional labeling and advertising for prescription human drugs, including biological drug products, and prescription animal drugs and articulates the circumstances under which FDA intends to exercise enforcement discretion. 2013-11-20 2013 11 https://www.federalregister.gov/documents/2013/11/20/2013-27770/draft-guidance-for-industry-on-product-name-placement-size-and-prominence-in-advertising-and https://www.govinfo.gov/content/pkg/FR-2013-11-20/pdf/2013-27770.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling." When finalized, the draft guidance will replace the...

Links from other tables